VBH051002
Gore Viabahn Endoprosthesis with Heparin 5mm x 10cm, 120cm
$1,999.00
box of 1
Out of stock
Expiration:
In-Date
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
We currently do not have this item in stock, but we can email you as soon as it is available!
Medtronic Maxon Suture green 30" V-20 (SH) Taper
$199.00 box of 36
Medtronic Polysorb violet 30" GU-45 taper
$1.00 packets
Medtronic Chromic Gut 30" GS-22 taper
$148.00 box of 36
Medtronic Chromic Gut 36" GS-21 taper
$36.00 box of 36
Medtronic Maxon clear 18" P-14 cutting
$359.00 box of 36
Medtronic Chromic Gut 36" GS-24 (CT) Taper
$1.00 packets
Medtronic Chromic Gut 30" V-26 taper
$4.00 packets
Description
Viabahn Endoprosthesis
VBH051002
- Endoprosthesis Diameter 5mm
- Endoprosthesis Length: 10cm
- Working Length 120cm
- Delivery Profile 7F
- Vessel Diameter 4.0mm-4.7mm
- Guidewire Compatibility 0.035"
- Heparin Bioactive Surface
Additional information
| Size | 5.00mm |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Stent Length | 100mm |
| Unit | box of 1 |
| Usable Length | 120cm |
- FDA Product Code: NIP PFV
- FDA Product Code Name: Stent, Superficial Femoral Artery / System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
- GMDN Term Code: 66619
- GMDN Term Name: Peripheral artery endovascular stent-graft, drug-coated
- GMDN Term Description: A non-bioabsorbable tubular implantable device intended to maintain patency and improve luminal diameter of a peripheral artery (excludes aorta, coronary, pulmonary, and intracranial arteries), and that includes a heparin coating intended to prevent thrombotic vessel re-narrowing. It may be intended for implantation in an artery adjacent to the aorta (e.g., iliac, renal arteries), however it is not a dedicated component of an aortoiliac stent-graft assembly; it may additionally be intended for venous implantation. It is comprised of a metallic outer mesh-like structure with an inner synthetic polymer tube (endovascular graft).
